StrokeViewer’s AI stroke portfolio

We offer you an advanced AI stroke portfolio built to empower physicians to make informed treatment decisions anywhere, anytime.

AI stroke portfolio

Advanced techniques, best results

Built with precision

Automated vessel tracing

Our AI is built to accurately reconstruct the vasculature and trace precisely along the blood vessels until any potential thrombus is detected.
This unique approach ensures fewer LVOs are missed.

Trained using the most heterogeneous data

Handles suboptimal
scan quality

Trained on the renowned MR CLEAN and several other datasets that include patients across the world, so our AI can:

  • process thicker slices;
  • improve signal-to-noise-ratio;
  • accept images from less advanced scanners;
  • detect the phase of acquisition for quality assurance.
Non-black box approach

Highest sensitivity

Recent clinical studies show that our AI stroke algorithms’ high sensitivity and specificity give excellent accuracy, which is key to providing patients the treatment they deserve. Results are always visible, so any decisions are left to your own observation.

StrokeViewer's Banner

Choose AI Algorithms Trained on the Most Heterogenous Dataset

it’s about time

Detects subtle ICH & SAH hemorrhages

Hemorrhage detection

StrokeViewer's hemorrhage detection

This AI stroke algorithm detects subtle bleeds and notifies your team immediately. Results are displayed via a binary contour mask and multicolored likelihood map for easy interpretation.

  • Detection of subtle subarachnoid and intraparenchymal hemorrhages as well as other intracranial hemorrhages
  • Sensitivity of 97% & Specificity of 96%*
  • Auto-segmentation and volumetric measurements displayed through color-coded overlay

* Internal clinical validation study, 2023

Automating ASPECTS


StrokeViewer's output of ASPECTS

Output of a standardized ASPECT score in minutes. With automatic detection of hypodensity on NCCT scans, you can quickly interpret results and make the best treatment decision.

  • Alignment of the brain for easier reading of the scan
  • Automatic identification of the ASPECTS regions on NCCT
  • Delivers results with high consistency and reliability*

* Internal clinical validation study, 2021

Reducing the number of undetected LVO’s

LVO triaging

StrokeViewer's LVO triaging

You and your team are instantly notified of a suspected Large Vessel Occlusion (LVO). The notification takes you straight to the patient timeline, where you can enter and store key clinical information.

  • Access to results via your mobile device, email or PACS to diagnose an LVO patient faster
  • Occlusion detection (including distal M2 branch)
  • Outstanding sensitivity for occlusion detection, Sensitivity of 99% including ICA-T and M1 occlusions in the anterior circulation*

* HALO FDA application 2020

Precisely locating the LVO

LVO location

LVO location on desktop

Your team is notified of the precise location of a suspected occlusion immediately. The notification takes you directly to the scan, helping you save treatment time and reduce the risk of missing an LVO.

  • LVO identifier to pinpoint LVO location
  • You are navigated to the relevant slices containing the occlusion
  • Non-black box approach, meaning results are always visible for your own interpretation

* HALO FDA application 2020
* Fasen et al 2022

Quantitative measurements of the collateral circulation


Collateral assessment with StrokeViewer

An automated collateral score is given to you as a percentage. Visualization of the vessels combined with thrombus location helps you determine whether the patient will benefit from endovascular therapy.

  • Collateral status is the only proven treatment effect modifier currently in the clinical guidelines*
  • You are informed of the acquisition phase for quality assurance
  • The automated score is given as a quantitative collateral score and percentage of contralateral hemisphere, reducing interobserver variability

* A.M.M. Boers et al. AJNR 2018
* Internal clinical validation study, 2022

Automated quantification

Automated perfusion analysis

Automated perfusion analysis with StrokeViewer

Quantifying the ischemic core and penumbra helps determine the amount of brain tissue that could be salvaged with endovascular treatment.

  • Easy-to-interpret multicolored perfusion maps visible through our DICOM Viewer
  • Core and mismatch volumes with DEFUSE-3 criteria to help determine eligibility for treatment
  • Automated AIF, VOF and motion correction to standardize results
StrokeViewer Banner with Clot

Personalized Treatment

Discover Our Latest AI Stroke Algorithm Developments